Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for Decoy receptors 547 found (774 total)

alternate case: decoy receptors

Transforming growth interacting factor (73 words) [view diff] exact match in snippet view article find links to article

Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ascrinvacumab (37 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Somatomedin receptor (59 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Transforming growth factor (361 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lerdelimumab (84 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
RTK class III (66 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Seribantumab (63 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Activin type 1 receptors (143 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
T-cell growth factor (228 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Molgramostim (120 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
FGF15/19 (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lenograstim (149 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Imgatuzumab (124 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Futuximab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Patritumab (160 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Emibetuzumab (117 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF22 (203 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF20 (221 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Colony-stimulating factor (329 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Duligotuzumab (84 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Metelimumab (310 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Activin receptor (173 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Icrucumab (139 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nesvacumab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Keratinocyte growth factor (180 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Alacizumab pegol (35 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fasinumab (144 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Flanvotumab (59 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
I-SMAD (62 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tovetumab (148 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Epigen (200 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Quizartinib (314 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Dalotuzumab (40 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ganitumab (128 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein receptor (328 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Rilotumumab (127 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Glia maturation factor (106 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dusigitumab (89 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Persephin (386 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Necitumumab (161 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ertumaxomab (104 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA4 (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ficlatuzumab (87 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Promegapoietin (180 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Ciliary neurotrophic factor receptor (477 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Norwogonin (174 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trofinetide (313 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin 4 (410 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sargramostim (836 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Mubritinib (141 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Robatumumab (178 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Becaplermin (421 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
7,8,3'-Trihydroxyflavone (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Infigratinib (290 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trafermin (301 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Insulin-like growth factor-binding protein (467 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tumor necrosis factor superfamily (301 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Foretinib (198 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ANA-12 (561 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CSPG5 (456 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Diosmetin (133 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fresolimumab (381 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF3 (790 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FMS-like tyrosine kinase 3 ligand (475 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Figitumumab (298 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Stamulumab (443 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF6 (603 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Onartuzumab (424 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fulranumab (205 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Angiopoietin receptor (223 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Icotinib (668 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Linsitinib (286 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tavilermide (391 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Growth factor receptor (584 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Grandinin (359 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Toceranib (281 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin 2 (707 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
INHBC (488 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Cenegermin (264 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
LEFTY2 (237 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GFRA3 (644 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Radotinib (331 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP6 (941 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
LM22A-4 (300 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF11 (165 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Canertinib (241 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Rociletinib (122 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Thrombopoietin (1,064 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Eutropoflavin (324 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 8A (280 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
R13 (drug) (257 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cyclotraxin B (301 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Enasidenib (405 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Masitinib (706 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
SB-431542 (397 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Lipegfilgrastim (398 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
MST1 (898 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dacomitinib (294 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
PDGFB (425 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Semaxanib (400 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mecasermin (274 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cediranib (642 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ancestim (278 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A3 (672 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP5 (898 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF7 (465 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF17 (681 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA2 (gene) (812 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF1 (566 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Zalutumumab (794 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP2 (883 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A2 (671 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Evinacumab (560 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dihexa (570 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ANGPT4 (668 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin (860 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lestaurtinib (1,565 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
PDGFD (790 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Hepatoma-derived growth factor (894 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Olaratumab (896 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A4 (656 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
K252a (281 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trk receptor (2,957 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF16 (271 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nimotuzumab (803 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Gossypetin (184 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Larotrectinib (545 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Regorafenib (826 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Growth differentiation factor (1,271 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Matuzumab (842 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Activin type 2 receptors (580 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
TGF beta signaling pathway (2,089 words) [view diff] exact match in snippet view article find links to article
or negatively, including the agonists for ligands and R-SMADs, the decoy receptors, and the ubiquitination of R-SMADs and receptors. Both chordin and
Mothers against decapentaplegic homolog 5 (240 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ramucirumab (1,259 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Avapritinib (1,035 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cixutumumab (615 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tivozanib (962 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin B1 (1,095 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF7 (1,229 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF15 (731 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP4 (1,220 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
VEGF receptor (754 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lenvatinib (903 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
INHA (964 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Motesanib (946 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lymphotoxin (1,458 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Neurotrophin-4 (946 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Thrombopoietin receptor (1,525 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Murodermin (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Artemin (1,183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 10 (525 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GDF3 (892 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Murodermin (80 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 9 (369 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Chordin (1,283 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GDF10 (590 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Mothers against decapentaplegic homolog 1 (466 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Lymphotoxin beta (1,440 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Cerebrolysin (1,099 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 8B (597 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Des(1-3)IGF-1 (346 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TNF receptor superfamily (496 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Ephrin B2 (1,306 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BMPR1B (523 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Teprotumumab (925 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BAMBI (929 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
HIOC (368 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bosutinib (505 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Gremlin (protein) (1,235 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
IGFBP1 (1,045 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Deoxygedunin (613 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
MST1R (1,086 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta receptor 2 (942 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Bone morphogenetic protein 3 (764 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tanezumab (647 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
INHBA (1,108 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Brigatinib (680 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lymphotoxin beta receptor (1,507 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Ripretinib (1,117 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
R-SMAD (303 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
ACVR1C (894 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
PDGFA (1,076 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A5 (1,204 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Filgrastim (1,477 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Tyrosine kinase inhibitor (1,081 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
LTBP1 (gene) (1,023 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Olmutinib (365 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Growth factor (1,115 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BNN-27 (615 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF6 (1,278 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
PDGFC (1,362 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pralsetinib (677 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA6 (631 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ANGPT2 (1,113 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF18 (1,086 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Transforming growth factor beta family (577 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tepotinib (696 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Axitinib (1,089 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA1 (1,487 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sorafenib (2,615 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Epiregulin (1,147 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRA1 (1,487 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta 2 (893 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
BNN-20 (572 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurturin (1,465 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF6 (1,278 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
C-fos-induced growth factor (1,234 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pegfilgrastim (1,486 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Adrenomedullin (1,430 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF15 (661 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Osimertinib (1,211 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Capmatinib (1,061 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mecasermin rinfabate (1,227 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lefty (protein) (1,323 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Selpercatinib (1,250 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR2B (1,344 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
ACVR2A (1,425 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
N-Acetylserotonin (1,144 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Alectinib (805 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF10 (1,330 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A1 (611 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHB6 (702 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CTGF (1,535 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Panitumumab (1,418 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA7 (709 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGF-1 LR3 (410 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Oncomodulin (1,183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Renalase (1,782 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF12 (632 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor B2 (614 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF9 (1,796 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHA8 (760 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CSF2RB (191 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Vascular endothelial growth factor B (1,499 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Amivantamab (1,136 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin A1 (1,161 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPHB3 (933 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR1 (1,058 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
EPH receptor A5 (692 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pazopanib (1,274 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Poly(A)-specific ribonuclease (1,334 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Trametinib (563 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tucatinib (1,462 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BMPR2 (1,147 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Fibroblast growth factor 23 (1,533 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tropomyosin receptor kinase C (3,892 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVR1B (1,537 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
TGF-beta receptor family (460 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Palifermin (1,286 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Palifermin (1,286 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pegaptanib (1,223 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sprifermin (308 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Platelet-derived growth factor receptor (1,562 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF5 (1,075 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Neratinib (1,202 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neurotrophic factor receptor (668 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pleiotrophin (1,643 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Binimetinib (995 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin B3 (1,020 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin 34 (278 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Lorlatinib (915 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trastuzumab deruxtecan (1,786 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor A3 (1,042 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta receptor 1 (1,559 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
ERBB4 (1,665 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Kinase insert domain receptor (793 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF13 (703 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ADCYAP1R1 (1,550 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor B4 (709 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Trastuzumab/hyaluronidase (703 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ceritinib (1,226 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
EPH receptor B1 (1,098 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Stem cell factor (2,941 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 15 (1,672 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Neurotrophin-3 (1,648 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
R7 (drug) (717 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Asciminib (953 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GFRα (109 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 6 (1,283 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Nepidermin (215 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Afatinib (1,117 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Lapatinib (1,399 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cetuximab (1,963 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 6 (1,081 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF14 (876 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Amphiregulin (2,133 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 2 (1,369 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Ciliary neurotrophic factor (1,739 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cobimetinib (1,006 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Type II cytokine receptor (616 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Decorin (1,940 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
EPH receptor A4 (757 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Type I cytokine receptor (513 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Bone morphogenetic protein 5 (1,025 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
EPH receptor A2 (1,321 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Erythropoietin (3,323 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pituitary adenylate cyclase-activating peptide (1,667 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nilotinib (1,676 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Nilotinib (1,676 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Follistatin (1,892 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Crizotinib (1,842 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
BMPR1A (1,487 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Nerve growth factor (2,025 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta receptor (333 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Angiopoietin 1 (1,621 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ACVRL1 (1,793 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
FGF19 (2,553 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cabozantinib (1,705 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Erlotinib (1,906 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ephrin (2,473 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Gefitinib (1,986 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF5 (2,274 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor 8 (2,159 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CALCRL (1,688 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor 4 (1,288 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pertuzumab (2,003 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Hemopoietic growth factor (137 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fellutamide (249 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
FGF4 (2,069 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF alpha (2,051 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Pemigatinib (1,157 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tumor necrosis factor receptor 1 (2,176 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Insulin-like growth factor 2 (1,597 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGFBR3 (1,618 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Insulin-like growth factor (1,728 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Placental growth factor (1,950 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Decoy receptor 1 (978 words) [view diff] exact match in snippet view article find links to article
"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors". Science. 277 (5327): 818–21. doi:10.1126/science.277.5327.818. PMID 9242611
Transforming growth factor, beta 3 (1,811 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Entrectinib (2,076 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Decoy receptor 2 (897 words) [view diff] exact match in snippet view article find links to article
et al. (2000). "Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma
Sunitinib (3,033 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Growth factor receptor inhibitor (380 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IGFBP7 (2,493 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Daved H. Fremont (329 words) [view diff] exact match in snippet view article find links to article
interactions between host cytokines and poxviruses and herpesviruses decoy receptors and neutralization of West Nile virus by therapeutic antibodies. Fremont
EPHA10 (138 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 2 (1,922 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Crenolanib (2,039 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Midkine (2,364 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Endoglin (2,783 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Platelet-derived growth factor (2,879 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Epidermal growth factor (1,712 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor 3 (1,872 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Dasatinib (1,970 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Thrombospondin 1 (2,124 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Nodal homolog (2,181 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interleukin receptor (243 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Betacellulin (2,145 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Activin and inhibin (2,666 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
RET proto-oncogene (2,382 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Perakizumab (67 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Fibroblast growth factor (3,041 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ranibizumab (2,183 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Faralimomab (74 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Cardiotrophin 1 (167 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Faricimab (1,168 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDNF family of ligands (1,122 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fletikumab (117 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Dabrafenib (712 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tucotuzumab celmoleukin (65 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Erythropoietin receptor (3,408 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Hepatocyte growth factor (2,663 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Glial cell line-derived neurotrophic factor (2,592 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Selumetinib (2,139 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Ponatinib (1,663 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Noggin (protein) (2,310 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Monokine (132 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Basic fibroblast growth factor (2,267 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Receptor activity-modifying protein (494 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Heparin-binding EGF-like growth factor (2,593 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-28 receptor (1,125 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
ErbB (2,627 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Neuregulin 3 (2,553 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-20 receptor (116 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Vascular endothelial growth factor C (3,103 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Bone morphogenetic protein 7 (2,562 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
GDF2 (2,610 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Pascolizumab (111 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interferon alfacon-1 (30 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Sifalimumab (99 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Thrombopoietin mimetics (76 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Neurotrophic factors (1,774 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Encorafenib (663 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Brolucizumab (1,233 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA6 (369 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Trastuzumab emtansine (2,595 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Inolimomab (136 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-31 receptor (36 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Anrukinzumab (55 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IFNA21 (407 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
KIT (gene) (4,116 words) [view diff] exact match in snippet view article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TGF beta 1 (2,241 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
IFNA5 (397 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Vemurafenib (1,768 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA10 (456 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNA14 (475 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Lymphokine (183 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fezakinumab (168 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-11 receptor (95 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Neurotrophin (3,077 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interferon alpha-n3 (28 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Basiliximab (268 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Receptor tyrosine kinase (3,069 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sirukumab (257 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Fibroblast growth factor receptor 2 (1,848 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Tropoflavin (2,217 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-22 receptor (94 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Lymphotoxin alpha (2,791 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
Death receptor 5 (1,498 words) [view diff] exact match in snippet view article find links to article
"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors". Science. 277 (5327): 818–21. doi:10.1126/science.277.5327.818. PMID 9242611
Mothers against decapentaplegic homolog 7 (2,855 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
IFNW1 (586 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNA17 (555 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fontolizumab (144 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Bone morphogenetic protein (3,432 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Peficitinib (171 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Elsilimomab (181 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Proteoglycan 4 (3,735 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Rontalizumab (105 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Tropomyosin receptor kinase A (3,264 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA4 (521 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Ingenol mebutate (1,226 words) [view diff] exact match in snippet view article find links to article
after treatment with ingenol mebutate. In addition, the interleukin decoy receptors IL1R2 and IL13RA2 were induced, resulting in a reduction in the long-term
IFNA8 (448 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-18 receptor (182 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Nintedanib (2,687 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Clazakizumab (153 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Angiopoietin (2,100 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Fibroblast growth factor receptor-like 1 (710 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TRAIL (1,304 words) [view diff] exact match in snippet view article find links to article
that have variable affinity for different death (DR4 and DR5) and decoy receptors (DCR1 and DCR2) may allow selective targeting of cancer cells by controlling
Glucose-6-phosphate isomerase (2,994 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-15 receptor (105 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-12 receptor (146 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Vascular endothelial growth factor A (3,053 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
ERBB3 (2,750 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Midostaurin (566 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IL17RD (200 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Growth differentiation factor-9 (3,318 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Integrin (3,824 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Namilumab (276 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IL22RA2 (276 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Varlilumab (183 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
FGF1 (2,297 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Vorsetuzumab mafodotin (111 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Denileukin diftitox (237 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Olokizumab (215 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
CD153 (101 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Pacritinib (314 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Ephrin receptor (3,453 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cerberus (protein) (2,706 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interleukin-27 receptor (264 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
SMAD (protein) (4,579 words) [view diff] exact match in snippet view article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Tesevatinib (380 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNA7 (869 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Tropomyosin receptor kinase B (3,979 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
RAMP2 (1,169 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Mothers against decapentaplegic homolog 4 (3,437 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interferon gamma receptor 2 (196 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fas ligand (2,083 words) [view diff] exact match in snippet view article find links to article
National Library of Medicine. Sheikh MS, Fornace AJ (2000). "Death and decoy receptors and p53-mediated apoptosis". Leukemia. 14 (8): 1509–1513. doi:10.1038/sj
Neuregulin 1 (3,917 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Insulin-like growth factor 1 receptor (3,588 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
RAMP1 (1,113 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Benralizumab (250 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-1 receptor (231 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
PDGFRA (3,499 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Epoetin theta (224 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IL17RC (462 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Insulin-like growth factor 1 (3,637 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
GDF11 (4,016 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Vascular endothelial growth factor (4,474 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Cytokine receptor (423 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Gevokizumab (211 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Atiprimod (323 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
PDGFRB (3,400 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Guselkumab (890 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Pegsunercept (143 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Low-affinity nerve growth factor receptor (4,042 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TNF receptor associated factor (135 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Mothers against decapentaplegic homolog 3 (4,219 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Momelotinib (343 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-3 receptor (205 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin-7 receptor (506 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
RAMP3 (1,066 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Brodalumab (602 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Anti–vascular endothelial growth factor therapy (1,669 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
CD70 (231 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
C-Met inhibitor (3,549 words) [view diff] exact match in snippet view article find links to article
steps that regulate c-Met activation by antibodies, peptide agonists, decoy receptors and other biologic inhibitors or small molecules inhibitors. The c-Met
Lebrikizumab (478 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IGFBP3 (4,673 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin 20 receptor, beta subunit (505 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Abrocitinib (712 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Imatinib (5,956 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Janus kinase (972 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Urelumab (201 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Glycoprotein 130 (2,188 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Tyrosine kinase (5,121 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Adipokine (443 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Dehydroepiandrosterone sulfate (2,572 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Romiplostim (568 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Anifrolumab (691 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
CD120 (335 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Epoetin beta (302 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interferon alfa (530 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
HER2/neu (4,099 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Briakinumab (539 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL22RA1 (627 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
FGF21 (3,498 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Siltuximab (831 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 5 (1,293 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Rilonacept (409 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IFNA13 (878 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IFNK (758 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Tumor necrosis factor (5,019 words) [view diff] exact match in snippet view article find links to article
superfamily modulators LTB (TNFβ) Agonists: Lymphotoxin (α (TNFβ), β (TNFC)) Decoy receptors: Baminercept TNF (TNFα) Others TNF superfamily protein ligands: 4-1BBL
IFNA16 (925 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
IL36B (839 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Secukinumab (969 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
CCRL2 (514 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin 28 (721 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Prasterone sulfate (522 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-5 receptor (840 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL36A (869 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Enavatuzumab (41 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Fibroblast growth factor receptor 1 (4,985 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IFNB1 (851 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Amitriptyline/perphenazine (693 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Sarilumab (1,135 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL17RB (720 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 32 (793 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 27 receptor, alpha subunit (660 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Bevacizumab (6,289 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Interleukin-4 receptor (756 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL1F10 (872 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Anti-Müllerian hormone (4,820 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Peginesatide (565 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Ixekizumab (1,043 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Albinterferon (402 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin 20 receptor, alpha subunit (685 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Pertuzumab/trastuzumab/hyaluronidase (957 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
TNFSF9 (664 words) [view diff] exact match in snippet view article find links to article
Antibodies: Anifrolumab Faralimomab MEDI-545 Rontalizumab Sifalimumab Decoy receptors: Bifarcept IFNGR (γ, II) Agonists: Interferon gamma (IFN-γ) Interferon
Interleukin-8 receptor (950 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL17RA (851 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
IL1RL2 (600 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Trastuzumab (5,872 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
IL18RAP (713 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Dexamethasone (5,340 words) [view diff] exact match in snippet view article find links to article
Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against NGF: RBM-004 Decoy receptors: LEVI-04 (p75NTR-Fc) PDGF Agonists: Becaplermin Platelet-derived growth
Alpha-taxilin (1,057 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Interleukin 36 (546 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Myostatin (5,277 words) [view diff] exact match in snippet view article find links to article
Ascrinvacumab Kinase inhibitors: K-02288 ML-347 (LDN-193719, VU0469381) Decoy receptors: Dalantercept Other inhibitors: Disitertide ALK2 (ACVR1A) Agonists:
Interleukin 36 receptor antagonist (1,145 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin
Pitrakinra (780 words) [view diff] exact match in snippet view article find links to article
IL-1RA Isunakinra Antibodies: Canakinumab Gevokizumab Lutikizumab Decoy receptors: Rilonacept (IL-1 Trap) IL-2 Agonists: Adargileukin alfa Aldesleukin